Your browser doesn't support javascript.
loading
A protocol for a randomised double-blind placebo-controlled feasibility study to determine whether the daily consumption of flavonoid-rich pure cocoa has the potential to reduce fatigue in people with relapsing and remitting multiple sclerosis (RRMS).
Coe, S; Collett, J; Izadi, H; Wade, D T; Clegg, M; Harrison, J M; Buckingham, E; Cavey, A; DeLuca, G C; Palace, J; Dawes, H.
Afiliación
  • Coe S; 1Centre for Movement and Occupational Rehabilitation Sciences, Oxford Institute of Midwifery, Nursing and Allied Health Research, and Oxford Brookes Centre for Nutrition and Health, Oxford Brookes University, Oxford, OX30BP UK.
  • Collett J; 1Centre for Movement and Occupational Rehabilitation Sciences, Oxford Institute of Midwifery, Nursing and Allied Health Research, and Oxford Brookes Centre for Nutrition and Health, Oxford Brookes University, Oxford, OX30BP UK.
  • Izadi H; 3School of Engineering, Computing and Mathematics, Faculty of Technology, Design and Environment, Oxford Brookes University, Wheatley Campus, Room R2.32, Oxford, OX33 1HX UK.
  • Wade DT; 1Centre for Movement and Occupational Rehabilitation Sciences, Oxford Institute of Midwifery, Nursing and Allied Health Research, and Oxford Brookes Centre for Nutrition and Health, Oxford Brookes University, Oxford, OX30BP UK.
  • Clegg M; 1Centre for Movement and Occupational Rehabilitation Sciences, Oxford Institute of Midwifery, Nursing and Allied Health Research, and Oxford Brookes Centre for Nutrition and Health, Oxford Brookes University, Oxford, OX30BP UK.
  • Harrison JM; 1Centre for Movement and Occupational Rehabilitation Sciences, Oxford Institute of Midwifery, Nursing and Allied Health Research, and Oxford Brookes Centre for Nutrition and Health, Oxford Brookes University, Oxford, OX30BP UK.
  • Buckingham E; 1Centre for Movement and Occupational Rehabilitation Sciences, Oxford Institute of Midwifery, Nursing and Allied Health Research, and Oxford Brookes Centre for Nutrition and Health, Oxford Brookes University, Oxford, OX30BP UK.
  • Cavey A; 2Department of Neurology, Nuffield Department of Clinical Neuroscienes, University of Oxford, Oxford, OX3 9DU UK.
  • DeLuca GC; 2Department of Neurology, Nuffield Department of Clinical Neuroscienes, University of Oxford, Oxford, OX3 9DU UK.
  • Palace J; 2Department of Neurology, Nuffield Department of Clinical Neuroscienes, University of Oxford, Oxford, OX3 9DU UK.
  • Dawes H; 1Centre for Movement and Occupational Rehabilitation Sciences, Oxford Institute of Midwifery, Nursing and Allied Health Research, and Oxford Brookes Centre for Nutrition and Health, Oxford Brookes University, Oxford, OX30BP UK.
Article en En | MEDLINE | ID: mdl-29403649

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Pilot Feasibility Stud Año: 2018 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Pilot Feasibility Stud Año: 2018 Tipo del documento: Article Pais de publicación: Reino Unido